Latest News

Chemo-radionuclide therapy halts neuroendocrine cancer

Advanced cancer of the neuroendocrine system can lead to dismal prognoses, but a novel therapy is packing a punch by uniting powerful radionuclide treatment and chemotherapy drugs, revealed researchers. Neuroendocrine tumors (NETs) are those that develop within a multiplicity of organs throughout the body that have nerve cells and interact with the endocrine system through chemical signaling made possible with various hormones. These tumors usually develop along the intestines and lungs, but they can also be found in the pancreas and many other sites.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Emotional behavior altered after multiple exposures to anesthesia during infancy

  • Smallest 3-D camera offers brain surgery innovation

  • Study shows how investments reflected shift in environmental views

  • Who gets a transplant organ?

  • Long-term study links common psychiatric disorders with increased risk of violent reoffending in ex-prisoners

  • Do antipsychotic medications affect cortical thinning?

  • Diabetes and brain tangles may be linked independently of Alzheimer's disease

  • Neuron responsible for alcoholism found

  • Reward, aversion behaviors activated through same brain pathways

  • Hiring more minority teachers in schools gives fairer perception of discipline

  •